Association of Deficiency of Coagulation Factors (Prs, Prc, ATIII) and FVL Positivity with Preeclampsia and/or Eclampsia in Pregnant Women
Open Access
- 1 October 2014
- journal article
- Vol. 8 (4) , 5-11
Abstract
Thrombophilia is a pathological state of increased blood coagulability. It causes problems during pregnancy including preeclampsia, stillbirth, repeated abortions, and detached pair. Out of the most prevalent factors causing inherited thrombophilia, protein S (Prs), protein C (Prc), and antithrombin III (ATIII) deficiency, and Factor V Leiden (FVL) mutation could be mentioned. This study aimed to investigate association of these parameters with preeclampsia. In this case-control study, 142 pregnant women with preeclampsia referred to Obstetric Clinic of Hajar Hospital, southwest of Iran, were assigned to the case group after clinical laboratory tests and according to specialist point of view and 142 pregnant women with normal blood pressure were assigned to the control group. After obtaining consent and completing relevant questionnaire, a 4-cc blood sample was taken from the patients. Coagulation factors and FVL rate were measured and after 6 months patients were followed- up. Data analysis was done by SPSS software using t-test. In view of deficiency of Prs, Prc, and ATIII, no statistically significant association was observed between case and control groups (P>0.05). Statistical t-test indicated that the rate of FVL deficiency in pregnant patients with preeclampsia was significantly different from that in the control group (p=0.03). In addition, the body mass index of case group was significantly higher than that of control group prior to pregnancy (P=0.001). In case group, preeclampsia history contributed to development of current preeclampsia in contrast to control group (p<0.001). The patients of case group were followed up after 6 months in view of blood pressure and all had a normal mean blood pressure at the completion of the study. Measurement of FVL deficiency could help to decrease the unpleasant complications of vascular disorders during pregnancy. But, screening test for pre-eclampsia does not seem necessary to determine the deficiency of coagulation factors, Prs, Prc, and ATIII.Keywords
This publication has 25 references indexed in Scilit:
- Metformin Enhances Cisplatin Cytotoxicity by Suppressing Signal Transducer and Activator of Transcription–3 Activity Independently of the Liver Kinase B1–AMP-Activated Protein Kinase PathwayAmerican Journal of Respiratory Cell and Molecular Biology, 2013
- Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complicationsThe Journal of Maternal-Fetal & Neonatal Medicine, 2011
- Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical studyBlood Coagulation & Fibrinolysis, 2011
- Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complicationsHuman Reproduction, 2010
- The significance of genetic polymorphisms of factor V leiden and prothrombin in the preeclamptic polish womenJournal of Thrombosis and Thrombolysis, 2009
- Thrombophilia and its impact on pregnancyThrombosis Research, 2009
- [Thrombophilia in pregnancy: venous thromboembolism, fetal loss, preeclampsia, intrauterine growth restriction].2008
- The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction?American Journal of Obstetrics and Gynecology, 2008
- Dalteparin and Low-Dose Aspirin in the Prevention of Adverse Obstetric Outcomes in Women With Inherited ThrombophiliaJournal of Obstetrics and Gynaecology Canada, 2007
- The Risk of Recurrent Venous Thromboembolism in Men and WomenNew England Journal of Medicine, 2004